SA
STOCK ALARM
STOCK ALARM
SA
Menu
Demo
Log In
BIIB
(BIIB)
BIIB
Overview
Notebook
Intelligence
Chart
History
Fundmntls
TTM
Earnings
Analysts
News
Financials
Segments
Insiders
Institl.
DCF
Peers
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Home
Screener
Alerts
Search
More
Product Revenue Segments
Annual
Quarterly
Latest: 2025 (2025-12-31) · Total:
$9.62B
Segment
Revenue
Share
MS Product Revenues
$4.04B
42.0%
TYSABRI product
$1.67B
17.3%
SPINRAZA
$1.55B
16.1%
Fumarate
$1.43B
14.8%
Interferon
$945.6M
9.8%
Geographic Revenue Segments
Annual
Quarterly
Latest: 2025 (2025-12-31) · Total:
$5.94B
Segment
Revenue
Share
Non-US
$3.57B
60.1%
UNITED STATES
$2.37B
39.9%
Other
$0
0.0%
Source: SEC filings via FMP · Last updated May 25, 2026
Biogen Inc.
(BIIB)
$216.03
▲
14.07 (6.97%)
Chart
Share
Post on X
BIIB
Biogen Inc.
(BIIB)
NASDAQ
$216.03
▲
14.07 (6.97%)
Chart Studio
Share
BIIB